![]() You will strengthen your pelvic floor muscles by contracting as coached by the handheld control unit in combination with the deep muscle stimulation provided by InTone.Īt Home Therapy For Unwanted Bladder Leakage This verbal coaching uses the same directions that a therapist would use during a clinic visit. To keep your treatment simple, InTone talks you through your entire 12 minute session. InTone’s biofeedback uses an illuminated bar graph that shows you the strength of your pelvic floor contractions during the exercise portion of your session. Biofeedback refers to any treatment that gives you sensory based cues to help you control your body’s responses. In addition to internal muscle stimulation, InTone also provides you with voice-guided pelvic floor exercises using biofeedback to improve your response. Calming spasms of the bladder muscle allows you to “hold it” longer and avoid frequent trips to the bathroom. If you have a strong pelvic floor, you can do things like cough, sneeze, laugh or run without leakage. InTone provides vaginal muscle stimulation that strengthens the pelvic floor and inhibits the spasms of the bladder muscle. InControl Medical significantly improved upon and combined two proven treatments to provide you with the most effective treatment possible. Combination Therapy Works To Stop Bladder Leakage Now you can treat your bladder leakage safely and effectively in the comfort of your home. InTone was created with your needs in mind. Street Est of $1.InTone is a medical device that stops unwanted bladder leakage without pills, without surgery and without pain. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022Įarnings Flash (VIVE) VIVEVE MEDICAL Posts Q2 Revenue $1.8M, vs. Transcript : Viveve Medical, Inc., Q2 2022 Earnings Call, Aug 11, 2022 Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Method Patent for Treating Female Stress Urinary Incontinence Announces Notice of Allowance for Second U.S. announced that it expects to receive $0.014675 million in funding announced that it has received $0.014675 million in funding Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022Įarnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.7M Transcript : Viveve Medical, Inc., Q3 2022 Earnings Call, Nov 10, 2022 Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence ![]() Viveve Medical to Seek Strategic Alternatives Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study Unveils Cut in Workforce Expects Delisting From Nasdaq Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday Investors Digest More Big Bank Earnings, Weighing on US Equity Futures PURSUIT Trial for Treating Female Stress Urinary Incontinence Viveve Announces Topline Results from Pivotal U.S. Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday Sector Update: Health Care Stocks Sputtering in Tuesday Trading Sector Update: Health Care Stocks Finishing Near Intra-Day Lows ![]() Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |